Skip to main content

Home/ Healthcare 2.0/ Group items tagged Australia

Rss Feed Group items tagged

sureivfin

​Everything You Want to Know About Surrogacy in Australia! - 0 views

  •  
    If you are an Australian who is looking for the best Surrogacy in Australia, you must be having the right knowledge about all the given laws and guidelines.
Rachel Renner

You Can Stop Snoring Now! - 1 views

I have been looking for the best solution on How to Stop Snoring. In fact I have tried a number of anti-snoring products that all claimed to be effective yet, nothing happened. But when I tried Noi...

started by Rachel Renner on 13 Dec 12 no follow-up yet
vbcuremart

The Role of Healthcare Facilitators in Medical Tourism - 0 views

  •  
    Medical tourism is growing by leaps and bounds as people realize the benefits of cost saving and the excellent treatment they receive in countries other than their own. People from the CIS, for instance, had to look to European countries like Germany, France, and the UK for treatment and in all these countries the treatment is expensive not to speak of stay and travel. Asian countries like India, Thailand and Sri Lanka are proving to be the better alternatives. The deterrent is how to find the best facility at the best cost and proceed. This is where a healthcare facilitator steps in and takes care of everything much to the relief of the patient and his family. The vital bridge Healthcare facilitators act as the vital bridge between the patient and the treatment facility that matches their needs. If you are in the US, UK, Australia, the CIS countries or in any African country and wish to find the best facility in India, for instance, the facilitator is the one to get in touch with. They maintain a database of hospitals and surgeons across the country, know their specialization and how much treatment can cost. Healthcare facilitators put you in touch with a medical institution that will give the best in terms of quality of treatment and cost. They do this by first going through your medical records and getting their panel of medical experts to match the ailment with a hospital. Patients get the benefit of expertise and save time and a great deal of money in the process. Patients receive invaluable assistance in: * Travel to the hospital * Scheduling appointments * Recommendations so that they receive personalized care * Supervision by the facilitator's own doctor to ensure that everything is being done right and, if not, patients may be switched to another hospital * Assistance with documentation and paperwork * Assistance with the procurement of medications * Negotiating the best rate with a discount for stay and treatment * Assistance to fam
sofiawalker171

Trina Blum, Atwell - Cylex® profile - 0 views

  •  
    extremely passionate about enriching the lives of other women and enhancing their performance in sports, at work or life in general to help them create a life of greater happiness and fulfillment as being a professional clinical hypnotherapist in Atwell Australia.
sachin_cmi

High Prevalence of Primary Biliary Cholangitis and Approval and Launch of New Drugs to ... - 0 views

  •  
    Primary biliary cholangitis, also known as primary biliary cirrhosis, is an autoimmune disease of the liver. The auto-immune disorder can have a number of symptoms such as abdominal pain, fever, nausea, vomiting, abdominal bloating, diarrhea, liver tenderness or enlargement, jaundice, and ascites. In most of these symptoms, the patient may be experiencing inflammation at an early stage of the illness, although in some cases, symptoms do not appear until the disease has advanced to a more serious state. A definitive diagnosis can only be made by performing blood tests and ultrasound studies in order to determine the progression of the illness and its effects on the body. At an early stage, most patients who experience mild to moderate symptoms of primary biliary cholangitis exhibit no symptoms, whereas in some cases, symptoms manifest very quickly and rapidly worsen. In both conditions, the majority of affected individuals undergo treatment that is aimed at relieving pain and treating any complications that might occur. High prevalence of primary biliary cholangitis is expected to propel growth of the primary biliary cirrhosis drugs market. For instance, according to the study, 'Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis', published in Hepatology International in September 2019, the overall prevalence of primary biliary cholangitis was 118.75 cases per million in the Asia Pacific region, with the high, medium and low prevalence being in Japan and China (191.18 cases per million), New Zealand (99.16 cases per million) and South Korea and Australia (39.09 cases per million), respectively. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/high-prevalence-of-primary-biliary.html
sachin_cmi

Starpharma Holdings Limited Received a Patent for SPL7013 Ophthalmic Drops for Viral Co... - 0 views

  •  
    The growing incidence of viral conjunctivitis cases is driving the growth of the viral conjunctivitis drugs market. According to National Center for Biotechnology: 2017, adenovirus is the most common cause of viral conjunctivitis and up to 70% of cases of acute conjunctivitis are viral. The number of individuals affected by viral conjunctivitis is estimated to be as high as 15 to 20 million per year in the U.S. Additionally, a rising number of research and development activities for enhancing the effectiveness of viral conjunctivitis drugs is again projected to accelerate the growth of the market. For instance, in 2019, iVIEW Therapeutics Inc., a clinical-stage ophthalmology drug development company, announced the dosing of the first patient in Phase II clinical trial. iVIEW Therapeutics Inc. is testing the safety and efficacy of the IVIEW-1201 in patients (age ≥15 years) for the treatment of acute adenoviral conjunctivitis. In 2018, Starpharma Holdings Limited, a company headquartered in Australia, received a patent for SPL7013 ophthalmic drops for viral conjunctivitis from the U.S. Patent and Trademark Office. The patent has been granted to the company due to its broad claims for treating and preventing microbial infections of the eye, including adenoviral conjunctivitis, bacterial conjunctivitis, and other eye infections. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/08/starpharma-holdings-limited-received.html
Rachel Renner

Saving A Relationship By Easing Snoring Issues - 1 views

I almost lost my long term partner because of my snoring problem. He used to have a bad sleep and stayed awake at night because of the irritating noise I produced. There was nothing I can do about ...

started by Rachel Renner on 21 Nov 12 no follow-up yet
Edgar Anderson

Promote the Wonders of Good Nutrition - 1 views

Since I am a health advocate, I decided to build our all-healthy-food restaurant somewhere in Australia. Since I am not an expert with formulating the best menu that consist with all healthy ingred...

started by Edgar Anderson on 28 Dec 12 no follow-up yet
John MCcain

Joondalup Orthodontist: Radiant Smile for Life - 0 views

  •  
    Malocclusion? Crooked teeth? And whatever forms of deformities those can lower down confidence. So, if you are one of those there's no need to be shy Joondalup Orthodontist will help you!
shawnandrew

IV Ibuprofen Market is Expected to Reach $14.2 Million, Globally, by 2022 - 1 views

The U.S. is anticipated to remain the highest revenue-generating region during the forecast period, owing to the widespread adoption of IV Ibuprofen for treating pain and fever. However, Australia ...

healthcare Medical ibuprofen

started by shawnandrew on 28 Nov 18 no follow-up yet
1 - 10 of 10
Showing 20 items per page